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combination of SEs (nine SEs coded for by SaPIm1/n1 [18],
egc [19], and sep). Among those, TSST-1 may suppress the
mobility of polymorphonuclear neutrophils to infection sites
[18], allowing MRSA to invade tissues. Moreover, since Spa
protein binds to the tumour necrosis factor-a receptor of
tissue cells [20], Spa protein, with a shorter stem, of strain
NN33 (spa387) may allow MRSA to get closer to and dam-
age tissue cells effectively.
In addition to the prematurity (i.e. ELBW) of the patient
as a risk factor, a high-level combination of SEs (including
TSST-1), together with adhesins and Spa (spa387 variant),
could have contributed to the pathogenesis of fatal necrotiz-
ing fasciitis with sepsis and DIC.
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Abstract
Four cases of Streptococcus pyogenes infection due to an emm-type
11 strain, including one with a fatal outcome, occurred within a
seven-member family. All strains shared biotype 5, pyrogenic
exotoxin genes speB and speC, and resistance to kanamycin,
tetracycline, macrolides and lincosamides. The identity of SmaI
pulsed-ﬁeld gel electrophoresis patterns conﬁrmed their clonal
origin. This highlights the ability of S. pyogenes to spread rapidly
among family members. This ﬁrst report of a family outbreak due
to emm11 S. pyogenes reinforces the importance of surveillance of
close family contacts of individuals with invasive streptococcal
disease, and provides further support for antibiotic prophylaxis
among the elderly.
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Although community-acquired invasive infections due to
Streptococcus pyogenes are increasing worldwide, the recently
published outbreaks related to emm-type 11 were deemed
to be hospital acquired [1,2]. We identiﬁed a multiresistant
emm11 clone responsible for a family outbreak. The index
case, an 87-year-old woman, was hospitalized in the intensive
care unit for erysipelas of the leg associated with streptococ-
cal toxic shock syndrome. A strain of S. pyogenes was iso-
lated from blood and cutaneous swab. The patient received
intravenous amoxicillin plus clavulanic acid 1 g/6 h for 7 days,
combined for the ﬁrst 2 days with ciproﬂoxacin 200 mg/
12 h, and for the following 5 days with gentamicin 20 mg/
8 h. She was discharged with a prescription of oral amoxicil-
lin plus clavulanic acid 1 g/8 h for 15 days and recovered.
The 47-year-old daughter was hospitalized 7 days after
her mother because of fever and acute abdominal pain.
S. pyogenes was isolated from blood. A computed tomo-
graphy scan showed a retroperitoneal peri-aortic abscess.
She was treated with intravenous amoxicillin 3 g/6 h plus
gentamicin 180 mg/day for 8 days. She then received an oral
course of amoxicillin 2 g/8 h for 15 days and recovered
uneventfully.
The 82-year-old husband of the index case had a medical
history of coronary by-pass surgery and aneurysm of abdom-
inal aorta. He was hospitalized 10 days after his wife with
streptococcal toxic shock syndrome, and died several hours
after admission. Blood cultures yielded the same S. pyogenes
strain.
The 16-year-old grandson presented on the following day
with pharyngitis due to the same strain. Throat swab speci-
mens were not obtained from the remaining family members,
two adults, 33 and 48 years old, and a 10-year-old girl, who
were asymptomatic. They received an antibioprophylactic
treatment.
Identiﬁcation and typing techniques, performed as previ-
ously described, revealed that all the isolates were identical
[3,4]. Biotype 5 was determined by the presence of b-glucu-
ronidase and fermentation of methyl-b-D-glucopyranoside on
rapid ID32 STREP strips (bioMe´rieux, Marcy l’Etoile, France).
The strain was non T-typeable by slide agglutination with
type-speciﬁc antisera (Sevapharma, Praha, Czech Republic).
Antimicrobial susceptibility was tested by the disk diffusion
method according to the Comite´ de l’Antibiogramme de la
Socie´te´ Franc¸aise de Microbiologie guidelines (http://
www.sfm.asso.fr). MICs were determined by E-test (AES,
Chemuney, Bruz, France). The mefA, ermB, ermTR, tetO,
tetM, tetK and tetL genes involved in macrolide or tetra-
cycline resistance were searched by multiplex PCR [5]. The
strain was resistant to tetracycline (MIC = 24 mg/L, in rela-
tion to the presence of the tetM gene). It had high levels of
resistance to kanamycin (MIC ‡ 500 mg/L), erythromycin
and clindamycin (MICs ‡ 256 mg/L in relation to the pres-
ence of the ermB gene). Genes encoding the toxins or super-
antigens SpeA, SpeB, SpeC and Ssa were determined by a
multiplex PCR method [4]. The strain was positive for genes
speB and speC. The identical emm sequence-type 11 and
pulsed-ﬁeld gel electrophoresis pattern of all the isolates,
obtained as previously described, conﬁrmed their clonal ori-
gin (Fig. 1) [3].
In Europe and in the USA emm11 strains are associated
with invasive infections in < 5% of cases [6–9]. In France, for
example, in 2007 the three most prevalent types (emm1,
emm89, emm28) represented 60% of invasive strains. The
association of emm-type 11 isolates and ermB gene has been
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reported in France and in other European countries
[7,10,11]. In Spain, an emm-type 11 clone harboured both
ermB and tetM genes [12]. In S. pyogenes, tetracycline resis-
tance is usually associated with the tetM gene and has been
considered to be an important cofactor in the selection of
erythromycin resistance [13]. In the period 2003–2004,
higher rates of macrolide resistance were observed in France
and Italy compared with nine other European countries par-
ticipating in the Strep-EURO surveillance programme for
invasive S. pyogenes infections, whereas tetracycline resis-
tance was found in almost all participating countries [14].
High levels of resistance to kanamycin in S. pyogenes have
been previously reported, associated with emm-type 28 mul-
tiresistant strains (characterized by high levels of resistance
to bacitracin, erythromycin, clindamycin, kanamycin and
streptomycin), but not with emm-type 11 strains [3].
The spread of S. pyogenes strains among the close contacts
of infected persons is well recognized, especially in families
including children [15,16]. In the reported cluster, the index
case had erysipelas with positive blood cultures. The isolation
of S. pyogenes from the cutaneous swab supports the theory
of rapid transmission to family members sharing accommoda-
tion for several days. The attack rate was 57% (four out of
seven family members). Two invasive infections occurred
in elderly persons, one of them suffering from underlying
cardiac and vascular disease, but the third infection occurred
in an otherwise healthy woman without any known risk fac-
tor. Although secondary cases are rare in the community, the
relative risk of invasive disease among contacts has been
reported to vary from 20, when the exposure time was
< 24 h/week, to 200 times when it reached ‡ 24 h [17–19].
In recent years, the incidence of invasive S. pyogenes dis-
ease has increased worldwide. In France, the annual inci-
dence of bacteraemia increased from 1.7 per 100 000
inhabitants in 2002 to 2.7 per 100 000 in 2004, and
decreased to 2 per 100 000 in 2007 (http://www.invs.san-
te.fr). According to the French guidelines, antibioprophylaxis
is recommended to persons with increased risk for invasive
S. pyogenes disease (age > 65, intravenous drug use, cutane-
ous lesions, chickenpox, underlying pathology, cortico-
therapy). In addition, when one family member receives
antibioprophylaxis, all close contacts should be treated
(http://www.sante.gouv.fr/htm/dossiers/cshpf/a_mt_181105_
streptococcus.pdf). According to the UK guidelines, if two
cases or more occur in the same household within a 30-day
period, the entire household should receive chemoprophy-
laxis [20]. Moreover, household contacts should consult a
physician if any pathological sign or symptom appears during
the 30 days following the last contact with the index case.
This outbreak, due to a rarely reported emm-type 11
strain of S. pyogenes, demonstrates the importance of the
characterization of the molecular type to prompt application
of guidelines for the prevention of secondary cases among
household members. Indeed, with the increase of invasive
S. pyogenes disease in the community, greater numbers of
clusters of cases might be expected.
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Abstract
This is the ﬁrst study concerning the molecular epidemiology of
group A streptococcus in Serbia and includes 145 isolates from
patients with various infections during the period 2001–2007.
The emm types, superantigen proﬁle and susceptibility pattern
were determined. Among 31 emm types identiﬁed, the most
prevalent were emm6, emm12, emm1, and emm58. All isolates
showed uniform antimicrobial susceptibility to all tested antibiot-
ics, with the exception of tetracycline and erythromycin (41%
and 0.7% resistant strains, respectively). Signiﬁcant heterogeneity
of emm types was found, with a high frequency of emm6 and
emm58, as well as a considerable prevalence of tetracycline
resistance, and a low level of macrolide resistance.
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antigens
Original Submission: 22 September 2008; Revised Submis-
sion: 2 December 2008; Accepted: 18 December 2008
Editor: G. Pappas
Article published online: 9 June 2009
Clin Microbiol Infect 2010; 16: 295–298
10.1111/j.1469-0691.2009.02823.x
Corresponding author and reprint requests: V. Mijacˇ, Institute
for Microbiology and Immunology, Medical School, University of
Belgrade, Dr Subotic´a 1, 11000 Belgrade, Serbia
E-mail: veramijac@yahoo.com
Streptococcus pyogenes (group A streptococcus (GAS)) is a
common human pathogen that causes a variety of diseases,
which differ greatly in severity. An increase in the incidence
of severe GAS infection in the late 1980s [1] has prompted
surveillance studies of streptococcal diseases around the
world. A striking variation in emm type distribution in differ-
ent geographical regions has been observed [2,3]. In addition,
different clinical manifestations were related to particular
M/emm types [4,5]. Since there, there have been no available
studies concerning GAS epidemiology in Serbia; the aim here
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